GPT and metabolic dysfunction-associated steatotic liver disease: At 10 weeks of WD+CCl4, mice exhibited advanced MASLD (Fig. 5B, C), major increases in ALT and AST (Fig. 5D, E), as well as liver fibrosis (Fig. 5F, G).